ALPN

Alpine Immune Sciences, Inc. Common Stock
ALPN

Overview Fund Activity
Delisted

ALPN was delisted on the 17th of May, 2024.

Back to rankings

27 hedge funds and large institutions have $88.9M invested in Alpine Immune Sciences, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
27
Holders Change
+3
Holders Change %
+12.5%
% of All Funds
0.61%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
6
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
$2.18M
2
BCM
Bridgeway Capital Management
Texas
$434K
3
Millennium Management
Millennium Management
New York
$205K
4
Renaissance Technologies
Renaissance Technologies
New York
$756K
5
Victory Capital Management
Victory Capital Management
Texas
$577K

Top Sellers

1
DM
Deerfield Management
New York
$10.2M
2
SIM
Spark Investment Management
New York
$185K
3
VF
Virtu Financial
New York
$0
4
Deutsche Bank
Deutsche Bank
Germany
$193K
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Macquarie Group
26
Macquarie Group
Australia
$8K +$8K +700 New
PWM
27
Perigon Wealth Management
California
$2K – – –
VF
28
Virtu Financial
New York
– -$148K -12,791 Closed
JPMorgan Chase & Co
29
JPMorgan Chase & Co
New York
– -$30K -2,600 Closed
Acadian Asset Management
30
Acadian Asset Management
Massachusetts
– -$26K -2,265 Closed
1
2